RATIONALE: Depression is a frequent non-motor symptom in Parkinson's disease (PD) with increasing rates with the progression of the disease. Molecular imaging studies have shown a reduction of dopamine transporter (DAT) density in depressed PD patients (dPD); however, DAT role in the pathophysiology of PD depression is not clear since clinical matching was inappropriate and DAT reduction could be attributed to PD severity. OBJECTIVES: To further examine the role of DAT in PD depression, this study compared thoroughly matched depressed vs. non-depressed PD patients (ndPD). MATERIALS AND METHODS: Twenty PD patients (n = 10 ndPD; n = 10 dPD) matched for age and disease severity were submitted to brain SPECT imaging with [(99m)Tc]-TRODAT-1, a DAT radioligand. DAT-binding potential was calculated using regions of interest bilaterally drawn in the striatum, caudate, and putamen. Depression was defined according to Beck Depression Inventory (BDI; cut-off >18). RESULTS: Mean BDI scores were higher in dPD (25.0 +/- 5.6) than in ndPD patients (8.0 +/- 1.9, p < 0.0001). DAT density was greater on dPD especially in the left caudate (dPD 0.87 +/- 0.19 vs. ndDP 0.69 +/- 0.18, p = 0.02) and right putamen (dPD 0.37 +/- 0.07 vs. ndPD 0.28 +/- 0.13, p = 0.03) than in ndPD patients. CONCLUSION: Our results suggest that in vivo DAT density is increased in dPD patients as compared to ndPD, suggesting that DAT is implicated in the pathophysiology of PD depression.
RATIONALE: Depression is a frequent non-motor symptom in Parkinson's disease (PD) with increasing rates with the progression of the disease. Molecular imaging studies have shown a reduction of dopamine transporter (DAT) density in depressed PDpatients (dPD); however, DAT role in the pathophysiology of PD depression is not clear since clinical matching was inappropriate and DAT reduction could be attributed to PD severity. OBJECTIVES: To further examine the role of DAT in PD depression, this study compared thoroughly matched depressed vs. non-depressed PDpatients (ndPD). MATERIALS AND METHODS: Twenty PDpatients (n = 10 ndPD; n = 10 dPD) matched for age and disease severity were submitted to brain SPECT imaging with [(99m)Tc]-TRODAT-1, a DAT radioligand. DAT-binding potential was calculated using regions of interest bilaterally drawn in the striatum, caudate, and putamen. Depression was defined according to Beck Depression Inventory (BDI; cut-off >18). RESULTS: Mean BDI scores were higher in dPD (25.0 +/- 5.6) than in ndPD patients (8.0 +/- 1.9, p < 0.0001). DAT density was greater on dPD especially in the left caudate (dPD 0.87 +/- 0.19 vs. ndDP 0.69 +/- 0.18, p = 0.02) and right putamen (dPD 0.37 +/- 0.07 vs. ndPD 0.28 +/- 0.13, p = 0.03) than in ndPD patients. CONCLUSION: Our results suggest that in vivo DAT density is increased in dPDpatients as compared to ndPD, suggesting that DAT is implicated in the pathophysiology of PD depression.
Authors: T Murai; U Müller; K Werheid; D Sorger; M Reuter; T Becker; D Y von Cramon; H Barthel Journal: J Neuropsychiatry Clin Neurosci Date: 2001 Impact factor: 2.198
Authors: J H Meyer; S Krüger; A A Wilson; B K Christensen; V S Goulding; A Schaffer; C Minifie; S Houle; D Hussey; S H Kennedy Journal: Neuroreport Date: 2001-12-21 Impact factor: 1.837
Authors: E Broussolle; C Dentresangle; P Landais; L Garcia-Larrea; P Pollak; B Croisile; O Hibert; F Bonnefoi; G Galy; J C Froment; D Comar Journal: J Neurol Sci Date: 1999-07-01 Impact factor: 3.181
Authors: Daniel Weintraub; Andrew B Newberg; Mark S Cary; Andrew D Siderowf; Paul J Moberg; Galit Kleiner-Fisman; John E Duda; Matthew B Stern; David Mozley; Ira R Katz Journal: J Nucl Med Date: 2005-02 Impact factor: 10.057
Authors: Marcelo Q Hoexter; Gustavo Fadel; André C Felício; Mariana B Calzavara; Ilza R Batista; Marilia A Reis; Ming C Shih; Roger K Pitman; Sérgio B Andreoli; Marcelo F Mello; Jair J Mari; Rodrigo A Bressan Journal: Psychopharmacology (Berl) Date: 2012-06-15 Impact factor: 4.530